-
DiscoveryProbe™ L1023: Redefining Kinase Inhibitor Screening
2026-06-08
Explore how the DiscoveryProbe™ L1023 Anti-Cancer Compound Library enables unparalleled precision in kinase inhibitor screening for cancer research. This article reveals practical assay insights and unique applications beyond typical high-throughput workflows.
-
Cell Counting Kit-8 (CCK-8): Precision Assays in Cardiac Cel
2026-06-08
Delve into the advanced use of Cell Counting Kit-8 (CCK-8) for precise cell viability, proliferation, and cytotoxicity assessment in cardiovascular research. This article offers a unique analysis of CCK-8's role in studying myocardial cell fate and inflammation.
-
Optimizing Cell Proliferation Assays with Cell Counting Kit-
2026-06-07
Cell Counting Kit-8 (CCK-8) streamlines sensitive, high-throughput cell viability measurement with unmatched ease and reproducibility. Discover how APExBIO’s CCK-8 empowers experimental precision, especially in advanced metabolic and implant osteointegration studies.
-
Moxidectin: Macrocyclic Lactone Anthelmintic for Antifungal
2026-06-06
Moxidectin, long established for parasitic worm control, now enables potent antifungal synergy protocols by upregulating ergosterol in Candida albicans. This workflow-focused guide shows how APExBIO’s high-purity moxidectin streamlines experimental design, reproducibility, and translational antifungal innovation.
-
Iron Stress Remodels Enterocyte Metabolism and Inflammation
2026-06-05
Navazesh and Ji (2025) demonstrate how iron deficiency and excess, induced in IPEC-J2 enterocyte models, reprogram metabolic and inflammatory responses. Their integrated transcriptional and metabolomics approach uncovers distinct adaptations relevant for intestinal health and iron-targeted research.
-
Efficient Synthesis of Deuterium-Labeled Degarelix Acetate
2026-06-05
This study presents a streamlined 13-step synthesis for deuterium-labeled degarelix acetate, a key internal standard for pharmacokinetic studies of GnRH antagonists. The work enables improved metabolic tracing and supports clinical research on androgen-related diseases.
-
Cell Counting Kit-8 Plus: Pushing Senescence Research Forwar
2026-06-04
Explore how Cell Counting Kit-8 Plus enables advanced, sensitive measurement of cell viability and senolytic efficacy, with a unique focus on senescence-targeted research and mechanistic insights from recent breakthroughs.
-
Ferroptosis-Related Gene Signature and Atorvastatin in HCC P
2026-06-04
This study establishes a novel prognostic model for hepatocellular carcinoma (HCC) based on ferroptosis-related genes and identifies atorvastatin as a candidate agent for inducing ferroptosis in HCC cells. The results provide new directions for biomarker-driven prognosis and therapeutic strategies in HCC, highlighting the translational potential of targeting ferroptosis.
-
Bradford Protein Assay Kit (K4103): Reliable Quantification
2026-06-03
The Bradford Protein Assay Kit offers researchers a rapid, sensitive solution for quantifying protein concentrations in solution, minimizing assay time while maintaining accuracy. It is well-suited for routine protein concentration measurement in molecular biology, protein purification, and enzyme assay workflows, but is not recommended for samples containing high concentrations of detergents or strong chaotropes. Researchers seeking reproducible results with minimal sample input will find this kit a practical fit within its specified operational range.
-
Moesin as a Biomarker of Endothelial Injury in Sepsis Models
2026-06-03
This study identifies moesin (MSN) as a novel biomarker reflecting endothelial injury severity in sepsis, with serum levels closely linked to vascular permeability and organ dysfunction. By elucidating MSN’s mechanistic role in endothelial inflammation pathways, the research offers new translational opportunities for vascular injury assessment and prognostication in critical care.
-
CD8+ T Cells Drive Abscopal Effects in PD-1/TIGIT Blockade w
2026-06-02
This study reveals the potent synergy between radiotherapy and dual PD-1/TIGIT immune checkpoint blockade in eliciting abscopal tumor regression and durable immune memory, mediated primarily by CD8+ T cells. The findings provide mechanistic insight into overcoming immunotherapy resistance, with translational implications for cancer treatment strategies.
-
Catalpol Inhibits Liver Fibrosis via EphA2/FAK/Src-Glycolysi
2026-06-02
This study demonstrates that catalpol significantly reduces hepatic fibrosis by targeting the EphA2/FAK/Src signaling pathway and suppressing aerobic glycolysis in hepatic stellate cells. The findings reveal a direct molecular mechanism with translational implications for anti-fibrotic strategies and metabolic intervention in chronic liver disease.
-
Synergistic Meiotic Induction in Mouse SSCs via RA and Nutri
2026-06-01
This study establishes a robust protocol for inducing meiotic initiation in long-term cultured mouse spermatogonial stem cells (SSCs) using a combination of retinoic acid and nutrient restriction. The approach addresses a longstanding barrier in in vitro germline research and provides new insights into the interplay between metabolic cues and meiotic signaling.
-
3D Tissue-Engineered Epidermis Relieves Keratinocyte Apoptos
2026-06-01
He et al. present a nanoparticle-enabled 3D tissue-engineered epidermis (TEE) that promotes wound healing by supporting primary human keratinocyte viability and reducing mitochondrial oxidative stress. Their work demonstrates a sustained-release collagen scaffold that enhances cell adhesion, proliferation, and survival, offering a promising strategy for addressing large-area skin defects.
-
(S)-Mephenytoin for Organoid-Based CYP2C19 Metabolism: Proto
2026-05-31
(S)-Mephenytoin is a gold-standard CYP2C19 substrate pivotal for advanced pharmacokinetic and drug metabolism research. This in-depth article deciphers its unique mechanistic role and provides actionable protocols for organoid-based assays, highlighting cutting-edge insights from recent organoid innovations.